| 发明名称 |
PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS BY GLYCOPROTEIN VACCINES SYNTHESIZED IN ESCHERICHIA COLI |
| 摘要 |
Provided herein are immunogenic compositions and vaccines for the treatment and prevention of Staphylococcus aureus infections. These immunogenic compositions and vaccines comprise combinations of bioconjugates capsular polysaccharides that are N-linked to one or more carrier proteins. |
| 申请公布号 |
US2016303213(A1) |
申请公布日期 |
2016.10.20 |
| 申请号 |
US201415101626 |
申请日期 |
2014.12.03 |
| 申请人 |
GLYCOVAXYN AG |
发明人 |
WACKER Michael;KOWARIK Michael;WETTER Michael |
| 分类号 |
A61K39/085;A61K39/40 |
主分类号 |
A61K39/085 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A composition comprising a capsular polysaccharide type 8 that is N-linked to ClfA (CP8-ClFA), and a second N-glycosylated protein. |
| 地址 |
Schlieren CH |
